|
Volumn 136, Issue 11, 2009, Pages 815-816
|
Multifocal cutaneous leishmaniasis due to Leishmania infantum under adalimumab therapy;Leishmaniose cutanée multifocale à Leishmania infantum sous traitement par adalimumab
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPHOTERICIN B LIPID COMPLEX;
BREFELDIN A;
HLA B27 ANTIGEN;
METHOTREXATE;
METRONIDAZOLE;
NONSTEROID ANTIINFLAMMATORY AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ADULT;
ANAMNESIS;
ANKYLOSING SPONDYLITIS;
BIOLOGICAL THERAPY;
CASE REPORT;
CLINICAL ASSESSMENT;
CLINICAL EXAMINATION;
CLINICAL FEATURE;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
HUMAN;
LEISHMANIA INFANTUM;
LETTER;
LICHENOID;
OUTCOME ASSESSMENT;
POLYMERASE CHAIN REACTION;
SEROLOGY;
SKIN BIOPSY;
SKIN LEISHMANIASIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
AMPHOTERICIN B;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIPROTOZOAL AGENTS;
ANTIRHEUMATIC AGENTS;
FEMALE;
HUMANS;
LEISHMANIA INFANTUM;
LEISHMANIASIS, CUTANEOUS;
MIDDLE AGED;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 70749103894
PISSN: 01519638
EISSN: None
Source Type: Journal
DOI: 10.1016/j.annder.2009.05.008 Document Type: Letter |
Times cited : (14)
|
References (10)
|